ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 134

Lower Socioeconomic Status Associates With Increased Symptom Severity and Functional Impairment In Fibromyalgia

Mary-Ann Fitzcharles1, Emmanouil Rampakakis2,3, Peter A. Ste-Marie4, John S. Sampalis2,3 and Yoram Shir4, 1Rheumatology & Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, 2JSS Medical Research, Montreal, QC, Canada, 3Jewish General Hospital, McGill University, Montreal, QC, Canada, 4Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: fibromyalgia, functional status, severity and socioeconomic status

  • Tweet
  • Email
  • Print
Session Information

Title: Fibromyalgia, Soft Tissue Disorders and Pain I

Session Type: Abstract Submissions (ACR)

Background/Purpose: Persons with lower socioeconomic status (SES) have poorer health status for many medical conditions. Reasons for this finding are multiple, but access to care, health related behaviours and adherence likely play a role. As fibromyalgia (FM) is a clinical construct with psychosocial implications, it is possible that SES may influence symptom expression and severity. We have examined the effects of SES (measured as proxy by level of education) for disease severity in a cohort of FM patients.

Methods: In a prospective cohort study of patients with FM followed at a tertiary care multidisciplinary clinic, patients were stratified according to education level: high school or less (Group 1; N=99), college (Group 2; N=84), and university (Group 3; N=63). Demographic and disease severity measures included pain visual analog scale (VAS), patient global assessment disease activity (PGA), Fibromyalgia Impact Questionnaire (FIQ), Health Assessment Questionnaire (HAQ), McGill Pain Questionnaire (MPQ), Pain Disability Index (PDI), Pain Catastrophizing Scale (PCS), and anxiety and depression by Arthritis Impact Measurement Scale (AIMS). Between-group differences in discrete and continuous variables were assessed for statistical significance with the Chi-Square test and one-way analysis of variance, respectively. Linear regression was used to assess between-group differences in disease activity while adjusting for potential confounders.

Results: The cohort comprised 246 patients with a mean ± SD age of 47.8 ± 10.4 years, disease duration of 10.8 ± 9.8 years, and 91.1% female. Baseline values were: pain VAS 6.5 ± 2.3, PGA 6.7 ± 2.1, FIQ 67 ± 17, HAQ 1.19 ± .59, MPQ 41 ± 15, PDI 38 ± 14, PCS 29 ± 12, AIMS anxiety 6.3 ± 1.8, AIMS depression 4.9 ± 1.8, with a mean medication count of  2.6 ± 1.3 per patient. There were no significant differences between groups for the following parameters: disease duration, marital status, cigarette smoking, previous eating disorder or alcohol abuse, current medication categories, and total number of medications used per patient. Higher education was associated with greater use of alternative medicines (P<0.001) and chiropractic, massage or osteopathic treatments (P=0.021).  Lower education level was significantly associated with older age (P=0.039), previous drug abuse (P=0.016), current unemployment (P<0.001) and higher score in the following measures of symptom severity: PGA (P=0.019), FIQ (P=0.002), HAQ (P=0.001), MPQ (P=0.026), PDI (P=0.031), and PCS (P=0.015). These associations remained significant even upon adjusting for age and gender differences. No significant differences in pain severity, anxiety, and depression were observed between groups.

Conclusion: Similar to other health conditions, FM patients with lower SES reported greater symptom severity, functional impairment and unemployment, but not mood disorder. Although FM spans all socioeconomic groups, societal factors, rather than specific disease characteristics or mental status, appear to play an important role in patients’ perception of illness.


Disclosure:

M. A. Fitzcharles,

Purdue Pharma L.P.,

5,

Eli Lilly and Company,

5,

Pfizer Inc,

5,

Valeant,

5;

E. Rampakakis,
None;

P. A. Ste-Marie,
None;

J. S. Sampalis,
None;

Y. Shir,

Purdue Pharma L.P.,

8,

Paladin Labs,

8,

Paladin Labs,

5.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lower-socioeconomic-status-associates-with-increased-symptom-severity-and-functional-impairment-in-fibromyalgia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology